10 hasil untuk "Francesca Nacci"
Menampilkan 1–10 · 0,48 detik · RSS
-
Artikel Jurnal
Psychosomatic profile in patients with systemic sclerosis: results from an observational study
ObjectivesThe aim of the present study was to test whether the occurrence of psychosomatic syndromes in patients with systemic sclerosis (SSc) may influence psychopathological distress and well-being.MethodsA total of 276 outpatients with SSc were consecutively enrolled. Mental disorders were…
-
Artikel Jurnal Teks lengkap
Systemic Sclerosis Sera Impair Angiogenic Performance of Dermal Microvascular Endothelial Cells: Therapeutic Implications of Cyclophosphamide
In systemic sclerosis (SSc), dermal capillaries are progressively lost with consequent chronic tissue hypoxia insufficiently compensated by angiogenesis. Clinical studies reported that intravenous cyclophosphamide (CYC) may improve SSc-related peripheral microvascular damage. Recently, we showed…
Juga tersedia di: DOAJ
-
Artikel Jurnal
Endometriosis and fibromyalgia co-occurrence: A comparative study of patient history and clinical profile
Objective: To compare the clinical and anamnestic characteristics of women with endometriosis alone versus those with both endometriosis and comorbid fibromyalgia, in order to identify distinguishing features between the two groups. Materials and methods: A prospective observational study was…
-
Artikel Jurnal
Baricitinib in the treatment of rheumatoid arthritis: clinical and ultrasound evaluation of a real-life single-centre experience
Background: Ultrasound (US) is useful in monitoring RA patients, with the US7 score allowing grey-scale and power-Doppler (PD) semi-quantitative evaluation of synovitis and teno-synovitis. We evaluated real-life efficacy and safety of Baricitinib, an oral selective JAK1-2 inhibitor, in RA patients…
-
Artikel Jurnal
The switch from etanercept originator to SB4: data from a real-life experience on tolerability and persistence on treatment in joint inflammatory diseases
Aims: Switching from originator to biosimilar is part of current practice in inflammatory rheumatic musculoskeletal diseases (iRMDs) such as rheumatoid arthritis (RA), psoriatic arthritis (PsA) and axial spondylarthritis (axSpA), with evidences derived from both etanercept (ETN) to SB4-switching…
-
Artikel Jurnal
Switching from originator adalimumab to biosimilar SB5 in a rheumatology cohort: persistence on treatment, predictors of drug interruption and safety analysis
Aims: Medical and non-medical switching strategies have been adopted in Europe in the last few years. We aimed to investigate persistence on treatment with a SB5 Adalimumab (SB5) biosimilar after switching from Adalimumab (ADA) originator among patients with inflammatory rheumatic musculoskeletal…
-
Artikel Jurnal
Screening for Leishmania spp. infection in patients treated with biologic agents for immune-mediated inflammatory diseases: results of an Italian multicentric prospective study
Abstract Background Escalation in the use of biologic agents including tumor necrosis factor (TNF)-α inhibitors to treat immune-mediated inflammatory diseases (IMID) is linked to higher susceptibility of severe infections caused by intracellular pathogens, including Leishmania. Methods This…
-
Artikel Jurnal
Babesiosis in the immunocompromised population: Results from a multicentric cohort study conducted in Italy
Human babesiosis is an emerging zoonotic disease; diffused especially in some regions of the United States, it has been less frequently observed in other continents, including Europe. Serological surveys suggest that babesiosis could be more frequent than expected in European countries…